Д.С. Бордин
A5088558357- Helicobacter pylori-related gastroenterology studies
- Gastroesophageal reflux and treatments
- Eosinophilic Esophagitis
- Pancreatitis Pathology and Treatment
- Gastric Cancer Management and Outcomes
- Pancreatic and Hepatic Oncology Research
- Liver Disease Diagnosis and Treatment
- Gastrointestinal motility and disorders
- Esophageal and GI Pathology
- Veterinary medicine and infectious diseases
- Digestive system and related health
- Gastrointestinal disorders and treatments
- Celiac Disease Research and Management
- Esophageal Cancer Research and Treatment
- Biomarkers in Disease Mechanisms
- Microbial Metabolites in Food Biotechnology
- Diet, Metabolism, and Disease
- Gallbladder and Bile Duct Disorders
- Intestinal and Peritoneal Adhesions
- Diverticular Disease and Complications
- Nutrition and Health in Aging
- Microscopic Colitis
- Diabetes and associated disorders
- COVID-19 Clinical Research Studies
- Intestinal Malrotation and Obstruction Disorders
Tver State Medical University
2016-2025
Moscow Clinical Scientific Center
2016-2025
Moscow State University of Medicine and Dentistry
2019-2024
Ministry of Health of the Russian Federation
2016-2023
National Medical Association
2021
Bács-Kiskun Megyei Kórház
2020
North-Western State Medical University named after I.I. Mechnikov
2018
Scientific Research Institute of Healthcare Organization and Medical Management
2018
Central Research Institute of Epidemiology
2011-2014
American Neurogastroenterology and Motility Society
2012
The best approach for Helicobacter pylori management remains unclear. An audit process is essential to ensure clinical practice aligned with standards of care.International multicentre prospective non-interventional registry starting in 2013 aimed evaluate the decisions and outcomes H. by European gastroenterologists. Patients were registered an e-CRF AEG-REDCap. Variables included demographics, previous eradication attempts, prescribed treatment, adverse events outcomes. Data monitoring was...
INTRODUCTION: Antibiotic resistance is one of the main factors that determine efficacy treatments to eradicate Helicobacter pylori infection. Our aim was evaluate effectiveness first-line and rescue against H. in Europe according antibiotics resistance. METHODS: Prospective, multicenter, international registry on management (European Registry Management). All infected culture-diagnosed adult patients registered Spanish Association Gastroenterology-Research Electronic Data Capture from 2013...
Background: Bacterial antibiotic resistance changes over time depending on multiple factors; therefore, it is essential to monitor the susceptibility trends reduce impact effectiveness of various treatments. Objective: To conduct a time-trend analysis Helicobacter pylori antibiotics in Europe. Methods: The international prospective European Registry Management (Hp-EuReg) collected data all infected adult patients diagnosed with culture and antimicrobial testing positive results that were...
The purpose of the first multidisciplinary Consensus: to comprehensively analyze pathophysiological, clinical, and pharmacotherapeutic aspects syndrome increased epithelial permeability (SPEP) as one basic mechanisms development human pathology. Consensus presents structure three main levels cytoprotection: preepithelial, subepithelial, intercellular tight contacts in tissues endothelium is considered detail. clinical sections are devoted role SPEP diseases digestive system,...
INTRODUCTION: The safety of Helicobacter pylori eradication treatments and to what extent adverse events (AEs) influence therapeutic compliance in clinical practice are hardly known. Our aim was assess the frequency, type, intensity, duration AEs, their impact on compliance, for most frequently used “European Registry management.” METHODS: Systematic prospective noninterventional registry European gastroenterologists (27 countries, 300 investigators) management H. infection routine practice....
Objectives The long-term consequences of COVID-19 infection on the gastrointestinal tract remain unclear. Here, we aimed to evaluate prevalence symptoms and post-COVID-19 disorders gut–brain interaction after hospitalisation for SARS-CoV-2 infection. Design GI-COVID-19 is a prospective, multicentre, controlled study. Patients with without diagnosis were evaluated hospital admission 1, 6 12 months post hospitalisation. Gastrointestinal symptoms, anxiety depression assessed using validated...
Background and aims Autoimmune pancreatitis (AIP) is an immune-mediated disease of the pancreas with distinct pathophysiology manifestations. Our were to characterize type 1 AIP in a large pan-European cohort study effectiveness current treatment regimens. Methods We retrospectively analyzed adults diagnosed since 2005 or not-otherwise-specified 42 European university hospitals. Type was uniformly using specific diagnostic criteria. Patients 2 those who had undergone pancreatic surgery...
Managing Helicobacter pylori infection requires constant decision making, and each is open to possible errors.The aim was evaluate common mistakes in the eradication of H. pylori, based on "European Registry management".European management an international multicentre prospective noninterventional registry evaluating decisions outcomes by European gastroenterologists routine clinical practice.Countries recruiting more than 1000 patients were included (26,340 patients). The most (percentages)...
INTRODUCTION: Gastrointestinal (GI) symptoms in coronavirus-19 disease (COVID-19) have been reported with great variability and without standardization. In hospitalized patients, we aimed to evaluate the prevalence of GI symptoms, factors associated their occurrence, variation at 1 month. METHODS: The GI-COVID-19 is a prospective, multicenter, controlled study. Patients COVID-19 diagnosis were recruited hospital admission asked for after month, using validated Symptom Rating Scale...
Currently, the diagnostic strategy for chronic gastritis (CG) is aimed not just at fixing presence of gastric mucosal inflammation, but also cancer (GC) risk stratification in a particular patient. Modern classification approach with definition stage determines need, activities and frequency dynamic monitoring However, this attitude to patient suffering from CG was far always. The present publication literature review describing key milestones history research, description first observations...
Adherence to Helicobacter pylori (H. pylori) eradication treatment is a cornerstone for achieving adequate efficacy.
Abstract Chronic pancreatitis (CP) is an end-stage disease with no specific therapy; therefore, early diagnosis of crucial importance. In this study, data from 1315 and 318 patients were analysed acute (AP) CP registries, respectively. The population the AP registry was divided into (n = 983), recurrent (RAP, n 270) 62) groups. prevalence in combination AP, RAP2, RAP3, RAP4 RAP5 + 0%, 1%, 16%, 50% 47%, respectively, suggesting that three or more episodes a strong risk factor for CP....
Abstract Background The recent data on the prevalence of Helicobacter pylori ( H. ) infection in Russia are limited. aim study was to compare ambulatory settings 2017 and 2019 years. Materials Methods Subjects visiting primary care centers were invited take part study. status assessed by 13 C‐urea breath test (UBT). Data subjects' demography, previous treatment exposure, place residence collected all federal districts calendar years processed centrally. Results 19,875 subjects available for...
Bismuth quadruple therapies (BQTs) including bismuth, a proton pump inhibitor (PPI) and two antibiotics have been shown to be highly effective for treating
Experience in Helicobacter pylori eradication treatment of patients allergic to penicillin is very scarce. A triple combination with a PPI, clarithromycin (C), and metronidazole (M) often prescribed as the first option, although more recently use quadruple therapy bismuth (B), tetracycline (T), M has been recommended.To evaluate efficacy safety first-line rescue treatments "European Registry H management" (Hp-EuReg).A systematic prospective registry clinical practice European...
Background. Recently, there has been an increase in the prevalence of gastroesophageal reflux disease (GERD) Northern Europe, North America and East Asia. However data on GERD Russian population are very limited. Aim. To determine among Russia, clinical spectrum symptoms, main drugs used for treatment, rate their administration. Materials methods. The study was conducted from November 2015 to January 2017 8 cities Russia. A survey patients over age 18 years old visiting outpatient medical...